Ina Sarel
Plus aucun poste en cours
Profil
Ina Sarel worked as a Director of Research & Development at TheraVitae, Inc., a Project Manager at Proneuron Biotechnologies, Inc., and a Vice President of Research & Development at Hemostemix, Inc. She holds a doctorate degree from Boston University and a graduate degree from The Hebrew University of Jerusalem.
Anciens postes connus de Ina Sarel
| Sociétés | Poste | Fin |
|---|---|---|
| HEMOSTEMIX INC. | Directeur Technique/Scientifique/R&D | - |
Proneuron Biotechnologies, Inc.
 Proneuron Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Proneuron Biotechnologies, Inc. develops therapies for nervous disorders. The company develops therapies for neurological, ophthalmologic and immune-related disorders such as spinal cord injuries, multiple sclerosis, glaucoma, Parkinson's disease and Alzheimer's diseases. It was founded in 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
TheraVitae, Inc.
 TheraVitae, Inc. BiotechnologyHealth Technology TheraVitae, Inc. developed and commercialized adult stem cell technologies. Its products were used to treat cardiovascular diseases. The company was headquartered in Toronto, Canada. | Directeur Technique/Scientifique/R&D | - |
Formation de Ina Sarel
| Boston University | Doctorate Degree |
| The Hebrew University of Jerusalem | Graduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HEMOSTEMIX INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
TheraVitae, Inc.
TheraVitae, Inc. BiotechnologyHealth Technology TheraVitae, Inc. developed and commercialized adult stem cell technologies. Its products were used to treat cardiovascular diseases. The company was headquartered in Toronto, Canada. | Health Technology |
Proneuron Biotechnologies, Inc.
Proneuron Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Proneuron Biotechnologies, Inc. develops therapies for nervous disorders. The company develops therapies for neurological, ophthalmologic and immune-related disorders such as spinal cord injuries, multiple sclerosis, glaucoma, Parkinson's disease and Alzheimer's diseases. It was founded in 1996 and is headquartered in New York, NY. | Health Technology |
